88 results
Page 2 of 5
8-K
EX-99.1
8bvtu 5js
27 Jun 22
Entry into a Material Definitive Agreement
7:31pm
8-K
EX-99.1
dm1s3bpjnl kaqmr9a
16 Jun 22
Other Events
7:00am
POS AM
EX-5.1
znzrl
28 Feb 22
Prospectus update (post-effective amendment)
5:46pm
POS AM
bqwo4
28 Feb 22
Prospectus update (post-effective amendment)
5:46pm
POSASR
EX-5.1
mwty6m uebbeyx
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:16pm
POSASR
axtg9 uwvsvi1
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:16pm
8-K
EX-99.1
6tcnnx
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
EX-99.2
b8vh 3qrej
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.2
f7xl07ae34mywoe4
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am